Search
for
Sort by
Research 61–90 of 1000+
- Evaluation of the efficacy and toxicity of oral and topical pumpkin oil on the hair growth of mice
- Incidence and management of cutaneous toxicities associated with cetuximab
- The risk of dermatological toxicities of combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma patients: a systematic review and meta-analysis
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Transepidermal UV radiation of scalp skin <i>ex vivo</i> induces hair follicle damage that is alleviated by the topical treatment with caffeine
- ROLE OF AYURVEDIC MANAGEMENT IN CHEMICAL TOXICITY OF COSMETICS: A REVIEW
- Iron: a cosmetic constituent but an essential nutrient for healthy skin
- The Double-Edged Sword of Epidermal Growth Factor Receptor Inhibitor: Rash as Toxicity and Prognostic Marker
- DGAT1 Modulates Hair Cycling and Is Essential for Retinoid Homeostasis in the Skin
- Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
- Dermatological adverse events with taxane chemotherapy
- Proliferative and Non-Proliferative Lesions of the Rat and Mouse Integument
- Anti-MRSA malleable liposomes carrying chloramphenicol for ameliorating hair follicle targeting
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer
- Prevention of erlotinib-induced folliculitis with doxycycline
- Hidradenitis suppurativa secondary to treatment with a gamma secretase inhibitor
- Periungual lesions secondary to chemotherapy with docetaxel
- Gene expression profiling of human keratinocytes exposed to the hair-dying agent, m-aminophenol
- Efficacy and safety of docetaxel in the elderly
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology
- Potential adverse effects of long-term testosterone therapy
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Safety of testosterone use in women
- Toxicological Studies on Procyanidin B-2 for Extern?al Application as a Hair Growing Agent
- Keratin‐based particles for protection and restoration of hair properties
- Leucoderma Associated with the Use of Topical Minoxidil: A Report of Two Cases
- Final Report on the Safety Assessment of Human Placental Protein, Hydrolyzed Human Placental Protein, Human Placental Enzymes, Human Placental Lipids, Human Umbilical Extract, Placental Protein, Hydrolyzed Placental Protein, Placental Enzymes, Placental Lipids, and Umbilical Extract